| Financial Year |
March 31 2023 |
| Monetary Funds |
392,609,218.41 |
| Held-for-trading Financial Assets |
45,000,000.00 |
| Notes Receivable |
45,456,491.00 |
| Accounts Receivable |
489,177,732.22 |
| Advances to Suppliers |
32,009,186.65 |
| Other Receivables |
33,399,267.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
604,778.58 |
| Inventories |
486,412,292.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
30,151,019.98 |
| Total Current Assets |
1,603,865,196.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
13,158,089.48 |
| Investment Properties |
-- |
| Fixed Assetes |
629,631,546.18 |
| Under-construction Projects |
27,118,920.76 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
184,066,992.26 |
| R&D expenses |
-- |
| Goodwill |
163,514,342.64 |
| Long-Term Deferred and Prepaid Expenses |
33,120,439.83 |
| Deferred Income Tax Assets |
114,731,287.96 |
| Other Non-Current Assets |
2,407,589.53 |
| Sub-Total of Non-Current Assets |
1,227,178,577.95 |
| Total Assets |
2,831,043,774.82 |
| Short-Term Loans |
669,561,604.53 |
| Trading Financial liabilities |
-- |
| Notes Payable |
180,191,811.67 |
| Accounts Payable |
260,814,096.56 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
33,715,995.71 |
| Taxes Payable |
21,667,237.36 |
| Interest Payable |
-- |
| Dividend Payable |
14,701,257.46 |
| Other payables |
247,417,700.64 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
110,654,635.60 |
| Other Current Liabilities |
17,897,787.15 |
| Sub-Total of Current Liabilities |
1,770,784,994.31 |
| Long-term Loans |
343,825,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
39,011,361.64 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
24,310,467.48 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
429,612,480.09 |
| Total Liabilities |
2,200,397,474.40 |
| Paid-In Capital(Or Share Stock) |
205,352,000.00 |
| Capital Surplus |
310,355,419.85 |
| Surplus Reserve |
32,215,550.99 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-15,515,054.40 |
| Minority Stockholder's Interest |
98,238,383.98 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
532,407,916.44 |
| Owner's Equity（Stockholder's Equity） |
630,646,300.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,831,043,774.82 |
